These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18029124)

  • 1. The ibogaine medical subculture.
    Alper KR; Lotsof HS; Kaplan CD
    J Ethnopharmacol; 2008 Jan; 115(1):9-24. PubMed ID: 18029124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.
    Popik P; Layer RT; Skolnick P
    Pharmacol Rev; 1995 Jun; 47(2):235-53. PubMed ID: 7568327
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatalities temporally associated with the ingestion of ibogaine.
    Alper KR; Stajić M; Gill JR
    J Forensic Sci; 2012 Mar; 57(2):398-412. PubMed ID: 22268458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.
    Noller GE; Frampton CM; Yazar-Klosinski B
    Am J Drug Alcohol Abuse; 2018; 44(1):37-46. PubMed ID: 28402682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute opioid withdrawal with ibogaine.
    Alper KR; Lotsof HS; Frenken GM; Luciano DJ; Bastiaans J
    Am J Addict; 1999; 8(3):234-42. PubMed ID: 10506904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.
    Brown TK; Alper K
    Am J Drug Alcohol Abuse; 2018; 44(1):24-36. PubMed ID: 28541119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review.
    Maciulaitis R; Kontrimaviciute V; Bressolle FM; Briedis V
    Hum Exp Toxicol; 2008 Mar; 27(3):181-94. PubMed ID: 18650249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication development of ibogaine as a pharmacotherapy for drug dependence.
    Mash DC; Kovera CA; Buck BE; Norenberg MD; Shapshak P; Hearn WL; Sanchez-Ramos J
    Ann N Y Acad Sci; 1998 May; 844():274-92. PubMed ID: 9668685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse.
    Luz M; Mash DC
    Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1019-1022. PubMed ID: 34139922
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].
    Kazlauskas S; Kontrimaviciūte V; Sveikata A
    Medicina (Kaunas); 2004; 40(3):216-9. PubMed ID: 15064541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.
    Corkery JM
    Prog Brain Res; 2018; 242():217-257. PubMed ID: 30471681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data accrue on "visionary" agent to interrupt addiction.
    Morris K
    Lancet; 1999 Nov; 354(9193):1883. PubMed ID: 10584734
    [No Abstract]   [Full Text] [Related]  

  • 13. Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences.
    Heink A; Katsikas S; Lange-Altman T
    J Psychoactive Drugs; 2017; 49(3):201-208. PubMed ID: 28266890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy.
    Mash DC
    Pharmacol Res; 2023 Apr; 190():106620. PubMed ID: 36907284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report.
    Cloutier-Gill L; Wood E; Millar T; Ferris C; Eugenia Socias M
    J Psychoactive Drugs; 2016; 48(3):214-7. PubMed ID: 27192438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DARK Classics in Chemical Neuroscience: Ibogaine.
    Wasko MJ; Witt-Enderby PA; Surratt CK
    ACS Chem Neurosci; 2018 Oct; 9(10):2475-2483. PubMed ID: 30216039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibogaine may help drug addicts live the 'never again'.
    Bateman C
    S Afr Med J; 2006 Jul; 96(7):580, 582. PubMed ID: 16909175
    [No Abstract]   [Full Text] [Related]  

  • 18. Ibogaine in the treatment of substance dependence.
    Brown TK
    Curr Drug Abuse Rev; 2013 Mar; 6(1):3-16. PubMed ID: 23627782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder - a narrative review.
    Arenson A; Campbell CI; Remler I
    J Addict Dis; 2024; 42(3):253-263. PubMed ID: 37199191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ibogaine - structure, influence on human body, clinical relevance].
    Zdrojewicz Z; Kuszczak B; Olszak N
    Pol Merkur Lekarski; 2016 Jul; 41(241):50-55. PubMed ID: 27734823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.